Enzyme may help protect against Alzheimer's

Image
IANS New York
Last Updated : Jun 05 2016 | 4:57 PM IST

Researchers have identified an enzyme that may help protect us against the debilitating effects of certain degenerative brain diseases, including Alzheimer's.

"This study found that NMNAT2, or nicotinamide mononucleotide adenylyl transferase 2, is a key neuronal maintenance factor," said lead researcher Hui-Chen Lu, Professor at Indiana University in the US.

"It exerts both an enzyme function to protect neurons from stress caused by over-excitation, and a 'chaperone' function, shown for the first time in this study, to combat the misfolded proteins encountered by the brain during ageing," Lu noted.

Many neurodegenerative disorders are caused by accumulation of proteins in the brain. These conditions, called proteinopathies, occur when proteins "misfold," causing them to grow "sticky" and clump up in the brain in a form often referred to as "plaques," or "tangles."

As a molecular chaperone, NMNAT2 binds to misfolded proteins to prevent or repair the errors that cause these clumps.

Common proteinopathies are Alzheimer's, Parkinson's and Huntington's diseases, as well as amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's Disease.

By examining NMNAT2 levels in brains donated by more than 500 elderly people whose cognitive function was tested annually before death, starting with the year of their enrollment in a clinical study established in 1997, Lu and colleagues found higher levels of NMNAT2 in people who had greater resistance to cognitive decline.

People with lower NMNAT2 were more likely to suffer from dementia, suggesting that the protein helps preserve neurons related to learning and memory.

Lu's team tested this hypothesis in mice whose brains were damaged by high levels of Tau, a toxic protein that correlates with disease progression.

They found that increasing the level of NMNAT2 in the hippocampus, a brain region important for learning and memory, significantly lowered levels of Tau.

The findings appeared in the journal PLOS Biology.

--IANS

gb/dg

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 05 2016 | 4:42 PM IST

Next Story